Omma Therapeutics

Founded by industry leaders with deep expertise and a proven track record in kallikrein-kinin system (KKS) drug discovery and development

Focused on advancing the untapped potential of targeting the KKS to address urgent medical needs and significantly change patient outcomes across a diverse set of therapeutic areas

Developing a prioritized pipeline to accelerate time-to-market and achieve both near-term milestones and enduring market value with a de-risked strategy for patients and investors alike

Scroll to Top